Literature DB >> 10224243

Caffeine-mediated override of checkpoint controls. A requirement for rhp6 (Schizosaccharomyces pombe).

R Rowley1, J Zhang.   

Abstract

Cells exposed to inhibitors of DNA synthesis or suffering DNA damage are arrested or delayed in interphase through the action of checkpoint controls. If the arrested cell is exposed to caffeine, relatively normal cell cycle progression is resumed and, as observed in checkpoint control mutants, loss of checkpoint control activity is associated with a reduction in cell viability. To address the mechanism of caffeine's action on cell progression, fission yeast mutants that take up caffeine but are not sensitized to hydroxyurea (HU) by caffeine were selected. Mutants 788 and 1176 are point mutants of rhp6, the fission yeast homolog of the budding yeast RAD6 gene. Mutant rhp6-788 is slightly HU sensitive, radiosensitive, and exhibits normal checkpoint responses to HU, radiation, or inactivation of DNA ligase. However, the addition of caffeine does not override the associated cell cycle blocks. Both point and deletion mutations show synthetic lethality at room temperature with temperature-sensitive mutations in cyclin B (cdc13-117) or the phosphatase cdc25 (cdc25-22). These observations suggest that the rhp6 gene product, a ubiquitin-conjugating enzyme required for DNA damage repair, promotes entry to mitosis in response to caffeine treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224243      PMCID: PMC1460602     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  58 in total

1.  Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells.

Authors:  R Schlegel; A B Pardee
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

2.  Progressive formation of DNA lesions in cultured Ehrlich ascites tumor cells treated with hydroxyurea.

Authors:  J C Li; E Kaminskas
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

Review 3.  Recovery, repair, and mutagenesis in Schizosaccharomyces pombe.

Authors:  J Phipps; A Nasim; D R Miller
Journal:  Adv Genet       Date:  1985       Impact factor: 1.944

4.  Modification of radiation-induced division delay by caffeine analogues and dibutyryl cyclic AMP.

Authors:  B F Kimler; D B Leeper; M H Snyder; R Rowley; M H Schneiderman
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1982-01

5.  Alpha-irradiation-induced G2 delay: a period of cell recovery.

Authors:  C Lücke-Huhle
Journal:  Radiat Res       Date:  1982-02       Impact factor: 2.841

6.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

7.  Abrogation of the effects of aphidicolin on NIH3T3 and V79 cells by caffeine.

Authors:  S K Das
Journal:  Biochim Biophys Acta       Date:  1987-04-02

8.  The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzyme.

Authors:  S Jentsch; J P McGrath; A Varshavsky
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

9.  Characterisation of Schizosaccharomyces pombe rad31, a UBA-related gene required for DNA damage tolerance.

Authors:  M Shayeghi; C L Doe; M Tavassoli; F Z Watts
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

10.  cdc25+ functions as an inducer in the mitotic control of fission yeast.

Authors:  P Russell; P Nurse
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

View more
  2 in total

1.  The transcription factor Pap1/Caf3 plays a central role in the determination of caffeine resistance in Schizosaccharomyces pombe.

Authors:  Z Benko; C Fenyvesvolgyi; M Pesti; M Sipiczki
Journal:  Mol Genet Genomics       Date:  2004-02-03       Impact factor: 3.291

2.  The involvement of Srs2 in post-replication repair and homologous recombination in fission yeast.

Authors:  Claudette L Doe; Matthew C Whitby
Journal:  Nucleic Acids Res       Date:  2004-03-01       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.